PRAX Praxis Precision Medicines, Inc | US74006W2070
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 342.357.440 | 2.289.180 | 14855.46% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | -9,66 | -15,32 | 36.98% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 15 | 16 | 6.25% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |